🚀 VC round data is live in beta, check it out!
Charles River Valuation Multiples
Discover revenue and EBITDA valuation multiples for Charles River and similar public comparables like Bio-Techne, ICON plc, Bangkok Dusit Medical Services, Sonic Healthcare and more.
Charles River Overview
About Charles River
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company’s research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Founded
1994
HQ
Employees
19.7K
Website
Financials (LTM)
EV
$11B
Charles River Financials
Charles River reported last 12-month revenue of $4B and EBITDA of $973M.
In the same LTM period, Charles River generated $1B in gross profit, $973M in EBITDA, and $521M in net income.
Revenue (LTM)
Charles River P&L
In the most recent fiscal year, Charles River reported revenue of $4B and EBITDA of $972M.
Charles River expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $4B | XXX | $4B | XXX | XXX | XXX |
| Gross Profit | $1B | XXX | $1B | XXX | XXX | XXX |
| Gross Margin | 34% | XXX | 33% | XXX | XXX | XXX |
| EBITDA | $973M | XXX | $972M | XXX | XXX | XXX |
| EBITDA Margin | 24% | XXX | 24% | XXX | XXX | XXX |
| EBIT Margin | 20% | XXX | 20% | XXX | XXX | XXX |
| Net Profit | $521M | XXX | $512M | XXX | XXX | XXX |
| Net Margin | 13% | XXX | 13% | XXX | XXX | XXX |
| Net Debt | — | — | $2B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Charles River Stock Performance
Charles River has current market cap of $9B, and enterprise value of $11B.
Market Cap Evolution
Charles River's stock price is $178.61.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $11B | $9B | 0.0% | XXX | XXX | XXX | $10.41 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCharles River Valuation Multiples
Charles River trades at 2.8x EV/Revenue multiple, and 11.5x EV/EBITDA.
EV / Revenue (LTM)
Charles River Financial Valuation Multiples
As of March 19, 2026, Charles River has market cap of $9B and EV of $11B.
Equity research analysts estimate Charles River's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Charles River has a P/E ratio of 16.9x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $9B | XXX | $9B | XXX | XXX | XXX |
| EV (current) | $11B | XXX | $11B | XXX | XXX | XXX |
| EV/Revenue | 2.8x | XXX | 2.8x | XXX | XXX | XXX |
| EV/EBITDA | 11.5x | XXX | 11.5x | XXX | XXX | XXX |
| EV/EBIT | 14.0x | XXX | 14.0x | XXX | XXX | XXX |
| EV/Gross Profit | 8.1x | XXX | 8.4x | XXX | XXX | XXX |
| P/E | 16.9x | XXX | 17.2x | XXX | XXX | XXX |
| EV/FCF | 22.0x | XXX | 21.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Charles River Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Charles River Margins & Growth Rates
Charles River's revenue in the last 12 month grew by 1%.
Charles River's revenue per employee in the last FY averaged $0.2M.
Charles River's rule of 40 is 25% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Charles River's rule of X is 26% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Charles River Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 1% | XXX | 0% | XXX | XXX | XXX |
| EBITDA Margin | 24% | XXX | 24% | XXX | XXX | XXX |
| EBITDA Growth | 2% | XXX | 1% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 25% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 26% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 23% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Charles River Public Comps
See public comps and valuation multiples for other Contract Research & Manufacturing and Laboratory Services comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Bio-Techne | XXX | XXX | XXX | XXX | XXX | XXX |
| ICON plc | XXX | XXX | XXX | XXX | XXX | XXX |
| Bangkok Dusit Medical Services | XXX | XXX | XXX | XXX | XXX | XXX |
| Sonic Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| ALS | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Charles River M&A Activity
Charles River acquired XXX companies to date.
Last acquisition by Charles River was on XXXXXXXX, XXXXX. Charles River acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Charles River
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialCharles River Investment Activity
Charles River invested in XXX companies to date.
Charles River made its latest investment on XXXXXXXX, XXXXX. Charles River invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Charles River
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Charles River
| When was Charles River founded? | Charles River was founded in 1994. |
| Where is Charles River headquartered? | Charles River is headquartered in United States. |
| How many employees does Charles River have? | As of today, Charles River has over 19K employees. |
| Who is the CEO of Charles River? | Charles River's CEO is James C. Foster. |
| Is Charles River publicly listed? | Yes, Charles River is a public company listed on NYSE. |
| What is the stock symbol of Charles River? | Charles River trades under CRL ticker. |
| When did Charles River go public? | Charles River went public in 2000. |
| Who are competitors of Charles River? | Charles River main competitors are Bio-Techne, ICON plc, Bangkok Dusit Medical Services, Sonic Healthcare. |
| What is the current market cap of Charles River? | Charles River's current market cap is $9B. |
| What is the current revenue of Charles River? | Charles River's last 12 months revenue is $4B. |
| What is the current revenue growth of Charles River? | Charles River revenue growth (NTM/LTM) is 1%. |
| What is the current EV/Revenue multiple of Charles River? | Current revenue multiple of Charles River is 2.8x. |
| Is Charles River profitable? | Yes, Charles River is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Charles River? | Charles River's last 12 months EBITDA is $973M. |
| What is Charles River's EBITDA margin? | Charles River's last 12 months EBITDA margin is 24%. |
| What is the current EV/EBITDA multiple of Charles River? | Current EBITDA multiple of Charles River is 11.5x. |
| What is the current FCF of Charles River? | Charles River's last 12 months FCF is $506M. |
| What is Charles River's FCF margin? | Charles River's last 12 months FCF margin is 13%. |
| What is the current EV/FCF multiple of Charles River? | Current FCF multiple of Charles River is 22.0x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.